Envalith Begins Research Coverage of I-ne, a D2C Brand Creator Accelerating Global Expansion with Brands like "BOTANIST" and Revenue Growth of Approximately 7x in 10 Years | Next-Generation Stock Research "ENVALITH"
Envalith Inc., a next-generation stock research platform provider, announced the initiation of research coverage for I-ne Co., Ltd., a D2C brand creator known for "BOTANIST" and "YOLU." A Q1 FY2026 earnings preview report was distributed today, aiming to deliver corporate value to global investors in three languages.
📋 Article Processing Timeline
- 📰 Published: May 14, 2026 at 00:57
- 🔍 Collected: May 13, 2026 at 16:02
- 🤖 AI Analyzed: May 13, 2026 at 18:31 (2h 29m after Collected)
Envalith Inc. (Headquarters: Shibuya-ku, Tokyo; Representative Director and President: Koichi Kawai; hereinafter "the Company"), which operates a next-generation stock research platform, is pleased to announce the initiation of research coverage for I-ne Co., Ltd. (Headquarters: Osaka-shi, Osaka; Representative Director and President: Yohei Onishi; Securities Code: 4933; hereinafter "I-ne"). In conjunction with the start of coverage, a Q1 FY2026 earnings preview report was distributed today.
Click here for the earnings preview.
Next-Generation Stock Research "ENVALITH"
ENVALITH is a next-generation stock research platform that delivers the corporate value of listed companies to institutional and individual investors, both domestic and international, in three languages: Japanese, English, and Chinese.
Flash reports immediately after earnings announcements: We conduct multifaceted analysis immediately after earnings announcements and investor briefings, and disseminate objective and neutral research and analysis from our independent perspective to the world in Japanese, English, and Chinese.
Global and direct distribution network: Globally, we provide multifaceted distribution covering terminals for global financial institutions such as Bloomberg, FactSet, Factiva, and AlphaSense, and domestically, we cover Kabutan, IFIS, QUICK, and SNS.
https://www.envalith.com
Comment from Koichi Kawai, Representative Director and President, Head of Global Investment Research Division:
We are very pleased to begin research coverage of I-ne, which since its founding in 2007, has consistently created D2C brands that resonate with consumers, such as "BOTANIST" and "YOLU," by leveraging its unique brand creation method "JBIST (Japan Branding Innovation System Technology)."
The company is currently expanding its business globally, both online and offline, with haircare, beauty appliances, cosmetics, and healthcare-related products at its core. It continues to grow as a Japan-originated beauty brand platformer, with overseas bases in Shanghai and the United States. A major focus of this fiscal year's earnings will be a multifaceted analysis from an analyst's perspective on the progress of multiple brand expansions and accelerated overseas development.
Envalith will contribute to the revitalization of Japan's capital markets by delivering the appeal of companies that build unique positions originating from Japan through such brand creation capabilities to global investors in Japanese, English, and Chinese.
Contact for inquiries regarding this matter:
Company Name
Envalith Inc.
Location
Cross C Shibuya Shinsen Building, 2-20 Shinsen, Shibuya-ku, Tokyo
Established
November 2025
Representative
Koichi Kawai, Representative Director and President, Head of Global Investment Research Division
Business Activities
Provision of next-generation stock research, IR support for companies
URL
https://www.envalith.com
X
https://x.com/envalith
E-mail
contact@envalith.com
Click here for the earnings preview.
Next-Generation Stock Research "ENVALITH"
ENVALITH is a next-generation stock research platform that delivers the corporate value of listed companies to institutional and individual investors, both domestic and international, in three languages: Japanese, English, and Chinese.
Flash reports immediately after earnings announcements: We conduct multifaceted analysis immediately after earnings announcements and investor briefings, and disseminate objective and neutral research and analysis from our independent perspective to the world in Japanese, English, and Chinese.
Global and direct distribution network: Globally, we provide multifaceted distribution covering terminals for global financial institutions such as Bloomberg, FactSet, Factiva, and AlphaSense, and domestically, we cover Kabutan, IFIS, QUICK, and SNS.
https://www.envalith.com
Comment from Koichi Kawai, Representative Director and President, Head of Global Investment Research Division:
We are very pleased to begin research coverage of I-ne, which since its founding in 2007, has consistently created D2C brands that resonate with consumers, such as "BOTANIST" and "YOLU," by leveraging its unique brand creation method "JBIST (Japan Branding Innovation System Technology)."
The company is currently expanding its business globally, both online and offline, with haircare, beauty appliances, cosmetics, and healthcare-related products at its core. It continues to grow as a Japan-originated beauty brand platformer, with overseas bases in Shanghai and the United States. A major focus of this fiscal year's earnings will be a multifaceted analysis from an analyst's perspective on the progress of multiple brand expansions and accelerated overseas development.
Envalith will contribute to the revitalization of Japan's capital markets by delivering the appeal of companies that build unique positions originating from Japan through such brand creation capabilities to global investors in Japanese, English, and Chinese.
Contact for inquiries regarding this matter:
Company Name
Envalith Inc.
Location
Cross C Shibuya Shinsen Building, 2-20 Shinsen, Shibuya-ku, Tokyo
Established
November 2025
Representative
Koichi Kawai, Representative Director and President, Head of Global Investment Research Division
Business Activities
Provision of next-generation stock research, IR support for companies
URL
https://www.envalith.com
X
https://x.com/envalith
contact@envalith.com